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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 























 Study aims to describe the clinical 
characteristics of COVID-19 and 
identify the risk factors for severe 
illness of COVID-19 in Jiangsu 
province, China. 
 In this case series in Jiangsu 
Province, COVID-19 patients had 
less severe symptoms and had 
better outcomes than the initial 
COVID-19 patients in Wuhan.  
 The BMI ≥ 28 kg/m2 and a known 
history of type 2 diabetes were 
independent risk factors of severe 
illness in patients with COVID-19. 
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 Study, estimates the additional 
maternal and under-5 child deaths 
resulting from the potential 
disruption of health systems and 
decreased access to food. 
 Least severe scenario (coverage 
reductions of 9·8–18·5% and 
wasting increase of 10%) over 6 
months would result in 253 500 
additional child deaths and 12 200 
additional maternal deaths.  
 Most severe scenario (coverage 
reductions of 39·3–51·9% and 
wasting increase of 50%) over 6 
months would result in 1 157 000 
additional child deaths and 56 700 













 Study aims to predict the impact of 
duration of exposure to COVID-19 
on the mortality rates increment.  
 COVID-19 infected top seven 
countries, Germany, China, France, 
United Kingdom, Iran, Italy and 
Spain, and World as a whole, were 
used for modeling.  
 The study adds information about 
the quantum of the severity and time 
elapsed to death to help the 
Government  take necessary and 















Short-term forecasts of healthcare demand for 
low- & middle-income countries showing: 
 Number of #COVID19 infections 
 Expected number of deaths next 14 
days 







 Impact of policy change 
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 We use the situation in Zimbabwe 
to build an argument that the 
epidemic is likely to be attenuated in 
some countries with similar socio-
economic and cultural structures.  
 However, even an attenuated 
epidemic may overwhelm weak 
health systems, emphasising the 
importance of prevention. These 
prevention strategies should be 
tailored to the unique social and 
cultural networks of individual 
countries which may facilitate the 
spread of SARS-CoV 2.  
 It is also equally important to 
maintain services for the major 
infectious diseases in the region 
such as tuberculosis and malaria. 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
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